Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.

European radiology - 1 Oct 2024

Yan Ran, Murakami Wakana, Mortazavi Shabnam, Yu Tiffany, Chu Fang-I, Lee-Felker Stephanie, Sung Kyunghyun

Abstract excerpt

OBJECTIVES: To compare the quantitative background parenchymal enhancement (BPE) in women with different lifetime risks and BRCA mutation status of breast cancer using screening MRI. MATERIALS AND METHODS: This study included screening MRI of 535 women divided into three groups based on lifetime risk: nonhigh-risk women, high-risk women without BRCA mutation, and BRCA1/2 mutation carriers. Six quantitative BPE...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Contrast Media

Share to Early Detection of Cancer

Share to Magnetic Resonance Imaging

Share to Risk Assessment

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 38683385
DOI: 10.1007/s00330-024-10758-9
PMCID: PMC11399191

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.PMID 38683385Read ↗

MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women.Semantic proximity Read ↗

Qualitative Assessments of Density and Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography Associated with Breast Cancer Risk of High-Risk WomenSemantic proximity Read ↗

Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.Semantic proximity Read ↗

The role of dynamic contrast-enhanced screening breast MRI in populations at increased risk for breast cancer.Semantic proximity Read ↗

Assessment of Background Parenchymal Enhancement and Lesion Kinetics in Breast MRI of BRCA 1/2 Mutation Carriers Compared to Matched Controls Using Quantitative Kinetic Analysis.Semantic proximity Read ↗

Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.Semantic proximity Read ↗

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis.Semantic proximity Read ↗

Comparison of background parenchymal enhancement and fibroglandular density at breast magnetic resonance imaging between BRCA gene mutation carriers and non-carriers.Semantic proximity Read ↗

Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?Semantic proximity Read ↗

MRI screening for breast cancer in high-risk patients.Semantic proximity Read ↗

The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.